围术期自体输血课件.ppt

输血管理-围术期自体输血出手术室的Hb/Hct标准Hb8-9g/dl；Hct25-27%ASAStatusⅠⅡ,年青Hb9-10g/dl；Hct28-30%ASAStatusⅢHb11-12g/dl；Hct33-35%ASAStatusⅣⅤ，老年人Hb＞12g/dl；Hct＞36%Overtransfusion过度输血输血管理-围术期自体输血??????????推荐类别?ClassIClassIIaClassIIbClassIII证据水平?BenefitRisk

治疗应当执行BenefitRisk

治疗有理由执行需要补充特定的研究BenefitRisk

治疗没有理由不执行需要补充广泛的研究Risk≥Benefit

治疗不应当执行因为无益或有害LevelA多个(3-5)人群的风险评估；一致的认识方向和明显的疗效。Recommendationthatprocedureortreatmentisuseful/effectiveSufficientevidencefrommultiplerandomizedtrialsormeta-analysesRecommendationinfavoroftreatmentorprocedurebeinguseful/effectiveSomeconflictingevidencefrommultiplerandomizedtrialsormeta-analysesRecommendationsusefulness/efficacylesswellestablishedGreaterconflictingevidencefrommultiplerandomizedtrialsormeta-analysesRecommendationthatprocedureortreatmentnotuseful/effectiveandmaybeharmfulSufficientevidencefrommultiplerandomizedtrialsormeta-analysesLevelB有限(2-3)人群的风险评估Recommendationthatprocedureortreatmentisuseful/effectiveLimitedevidencefromsinglerandomizedtrialornon-randomizedstudiesRecommendationinfavoroftreatmentorprocedurebeinguseful/effectiveSomeconflictingevidencefromsinglerandomizedtrialornon-randomizedstudiesRecommendationsusefulness/efficacylesswellestablishedGreaterconflictingevidencefromsinglerandomizedtrialornon-randomizedstudiesRecommendationthatprocedureortreatmentnotuseful/effectiveandmaybeharmfulLimitedevidencefromsinglerandomizedtrialornon-randomizedstudiesLevelC极有限(1-2)人群的风险评估Recommendationthatprocedureortreatmentisuseful/effectiveOnlyexpertopinion,casestudies,orstandard-of-careRecommendationinfavoroftreatmentorprocedurebeinguseful/effectiveOnlydivergingexpertopinion,casestudies,orstandard-of-careRecommendationsusefulness/efficacylesswellestablishedOnlydivergingexpertopinion,case